Arizona State University-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Arizona State University - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8010837
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月20日
◆ページ数:26
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Arizona State University (ASU) is an educational and research university that provides entrepreneurship solutions. The university’s services include academic services, knowledge enterprise development, institutes and initiative consulting, industry engagement, entrepreneurship, support and consulting, global development, technology transfer and undergraduate opportunity services. It offers academic services such as collage and school programs, degree programs, online degrees, academic calendar, libraries, registration and scholarships and financial aid services. ASU has partnership with private companies to advance their research. The university offers education services in the areas of arts and sciences, business, design and the arts, education, engineering, graduate, health solutions, honors, journalism and other sectors. It serves students, research organizations, partners and staffs. The university operates through its campuses in Tempe and Phoenix, the US. ASU is headquartered in Tempe, Arizona, the US.

Arizona State University – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Arizona State University, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Arizona State University, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Arizona State University, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Arizona State University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Arizona State University, Medical Devices Deals, 2011 to YTD 2017 9
Arizona State University, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Arizona State University, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Arizona State University Enters into Research Agreement with Banner Health 11
BioDesign Enters Into Research Agreement With Phoenix Children’s Hospital 12
Arizona State University Forms Joint Venture With Chang Gung University College 13
Licensing Agreements 14
Roche Diagnostics Enters Into Licensing Agreement With Arizona Technology And Columbia University 14
Helicos BioSciences Amends Licensing Agreement With Arizona Technology 15
Synbody Biotechnology Enters Into Option Agreement With Arizona State University 16
Equity Offering 17
Sonoran Biosciences to Raise Funds in Financing Round 17
Arizona State University – Key Competitors 18
Arizona State University – Key Employees 19
Arizona State University – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Joint Venture 22
Recent Developments 23
Strategy And Business Planning 23
Jul 22, 2016: Arizona Oncology breaks ground for state-of-the-art treatment center in the East Valley 23
Government and Public Interest 24
Dec 14, 2017: ASU scientists develop new, rapid pipeline for antimicrobials 24
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Tables
Arizona State University, Pharmaceuticals & Healthcare, Key Facts 2
Arizona State University, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Arizona State University, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Arizona State University, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Arizona State University, Deals By Therapy Area, 2011 to YTD 2017 8
Arizona State University, Medical Devices Deals, 2011 to YTD 2017 9
Arizona State University, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Arizona State University Enters into Research Agreement with Banner Health 11
BioDesign Enters Into Research Agreement With Phoenix Children's Hospital 12
Arizona State University Forms Joint Venture With Chang Gung University College 13
Roche Diagnostics Enters Into Licensing Agreement With Arizona Technology And Columbia University 14
Helicos BioSciences Amends Licensing Agreement With Arizona Technology 15
Synbody Biotechnology Enters Into Option Agreement With Arizona State University 16
Sonoran Biosciences to Raise Funds in Financing Round 17
Arizona State University, Key Competitors 18
Arizona State University, Key Employees 19
Arizona State University, Other Locations 21
Arizona State University, Subsidiaries 21
Arizona State University, Joint Venture 22

★海外企業調査レポート[Arizona State University-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Doppler SA:企業の戦略・SWOT・財務情報
    Doppler SA - Strategy, SWOT and Corporate Finance Report Summary Doppler SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Pine Cliff Energy Ltd (PNE):石油・ガス:M&Aディール及び事業提携情報
    Summary Pine Cliff Energy Ltd (Pine Cliff) is an oil and gas company that offers exploration, production, and development of natural gas, crude oil, and natural gas liquids. The company operates through its core areas such as Edson Assets, Central Assets, and Southern Assets. It acquired Hatton prop …
  • Epax Norway AS:企業の戦略・SWOT・財務情報
    Epax Norway AS - Strategy, SWOT and Corporate Finance Report Summary Epax Norway AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • African Phoenix Investments Limited:企業の戦略・SWOT・財務情報
    African Phoenix Investments Limited - Strategy, SWOT and Corporate Finance Report Summary African Phoenix Investments Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Biognosys AG-製薬・医療分野:企業M&A・提携分析
    Summary Biognosys AG (Biognosys) is a proteomics company that provides products and services for highly multiplexed protein quantification. The company offers products such as data independent acquisition data analysis software, smartest multiple reaction monitoring and parallel reaction monitoring …
  • Amazon Web Services Inc:企業の戦略・SWOT・財務分析
    Amazon Web Services Inc - Strategy, SWOT and Corporate Finance Report Summary Amazon Web Services Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Zetro Aerospace Corporation Sdn. Bhd.:企業の戦略・SWOT・財務情報
    Zetro Aerospace Corporation Sdn. Bhd. - Strategy, SWOT and Corporate Finance Report Summary Zetro Aerospace Corporation Sdn. Bhd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • New Gold Inc.:企業のM&A・事業提携・投資動向
    New Gold Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's New Gold Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • EVN AG (EVN)-エネルギー分野:企業M&A・提携分析
    Summary EVN AG (EVN) is an energy and environmental services company. It provides electricity, natural gas, heat, drinking water, wastewater treatment, thermal waste utilization, and related services. The company produces power from thermal and renewable sources. EVN procures electricity, natural ga …
  • Qatar Airways Group Q.C.S.C.:企業の戦略・SWOT・財務分析
    Qatar Airways Group Q.C.S.C. - Strategy, SWOT and Corporate Finance Report Summary Qatar Airways Group Q.C.S.C. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Aecon Group Inc (ARE):企業の財務・戦略的SWOT分析
    Aecon Group Inc (ARE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Agility Public Warehousing Co:企業の戦略・SWOT・財務情報
    Agility Public Warehousing Co - Strategy, SWOT and Corporate Finance Report Summary Agility Public Warehousing Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Analog Modules, Inc.:企業の戦略・SWOT・財務情報
    Analog Modules, Inc. - Strategy, SWOT and Corporate Finance Report Summary Analog Modules, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • OHB SE:企業の戦略・SWOT・財務情報
    OHB SE - Strategy, SWOT and Corporate Finance Report Summary OHB SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • Motif BioSciences Inc-製薬・医療分野:企業M&A・提携分析
    Summary Motif BioSciences Inc (Motif), a subsidiary of Motif Bio Plc is a clinical stage biopharmaceutical company that manufactures novel antibiotics designed to treat life-threatening infections caused by multi-drug resistant bacteria. The company’s product programs include MTF-001, iclaprim, and …
  • Bank of Communications Ltd (601328):企業の財務・戦略的SWOT分析
    Bank of Communications Ltd (601328) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • HABAU Hoch- und TiefbauGmbH:企業の戦略的SWOT分析
    HABAU Hoch- und TiefbauGmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • aap Implantate AG (AAQ):企業の財務・戦略的SWOT分析
    Summary aap Implantate AG (aap Implantate) is a medical device company, which develops, manufactures and markets trauma products and biomaterials for orthopedic treatment. Its products include locked plating systems for anatomical reduction, cannulated screws, standard plates and screws for osteosyn …
  • Discovery Inc (DISCA):企業の財務・戦略的SWOT分析
    Discovery Inc (DISCA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Ricoh Imaging Co Ltd:企業の戦略的SWOT分析
    Ricoh Imaging Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆